Beijing Cancer Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche1 trial
• LianBio LLC1 trial

Closed trials

• Terminated

  Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

  NCT06206278· Phase 2· LianBio LLC· Source

• Completed

  A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

  NCT04513925· Phase 3· Hoffmann-La Roche· Source